PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Resveratrol ameliorates hepatic injury and modulates hepatic biomarkers of regeneration, apoptosis and survival in a rat model of blunt hepatic trauma.

Rat / Crush

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32990006 ↗2020Reported benefit

Resveratrol ameliorates hepatic injury and modulates hepatic biomarkers of regeneration, apoptosis and survival in a rat model of blunt hepatic trauma.

RatCrushOther / unspecifiedWistar Albinon = 21 rats in total, n = 7 per group across three groupsIntraperitoneal injection10 mg/kgAfter induction of blunt hepatic trauma

Model: Blunt hepatic trauma

Resveratrol lowered serum AST, ALT and LDH relative to untreated trauma and reduced inflammation scores (1.42 plus or minus 0.53 versus 2.42 plus or minus 0.53, p = 0.001), with the highest Ki-67, Bcl-2 and Bax scores in the treated group.

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.